NCT02466204View on ClinicalTrials.gov

Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

June 1, 2015

Primary Completion Date

August 10, 2016

Study Completion Date

August 15, 2017

Conditions

Infertility

Interventions

DRUG

corifollitropin alfa

Drug is injected subcutaneously. Seven days after, 300 IU FSH daily injected subcutaneously, until at least two leading ovarian follicles reach 17mm in diameter.

DRUG

Follitropin Beta

Drug is injected subcutaneously, daily, until at least two leading ovarian follicles reach 17mm in diameter.

Trial Locations (2)

70000

My Duc Hospital, Ho Chi Minh City

Research Center for Genetics and Reproductive Health, Ho Chi Minh City

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Mỹ Đức Hospital

OTHER

lead

Vietnam National University

OTHER

NCT02466204 - Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients | Biotech Hunter | Biotech Hunter